Imperial College London

Professor Amin Hajitou

Faculty of MedicineDepartment of Brain Sciences

Professor of Targeted Therapeutics



+44 (0)20 7594 6546a.hajitou Website




Burlington DanesHammersmith Campus




Guest Lectures

Systemic Phagotherapy against Cancer: Where Are we Since the Dog Study of 2009?, Queen Mary University of London, London, United Kingdom, 2018

Bacteriophage: a bacteria virus that has potential to penetrate the blood-brain barrier to target brain tumours., Imperial College Neuroscience Society- Meeting of The Minds 2018., London, United Kingdom., 2018

Targeted gene transfer technologies to brain tumours through the blood brain barrier., 3rd Annual Neuroscience R&D Technologies Conference., London, 2017

Therapeutic targeting of brain tumours by a bacteria viral vector following intravenous administration., Glioma Club of the University College London., London, 2017

Towards an intravenous targeted cancer gene therapy mediated by a bacteria virus-based delivery vector, University of Exeter, Exeter, United Kingdom, 2017

Phage-guided Production of Recombinant Adeno-associated Virus, Pfizer Inc., London, United Kingdom, 2017

Towards a Bacteria Virus that Destroys Cancer. Where Are We Since 2006, Rabat Medical and Pharmacy School, University Mohammed V, Rabat, Morocco, 2016

Designing superior bacteriophage viral vectors that target and destroy tumours., The School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, 2015

Bacteria Viruses in Gene Therapy of Cancer., The Rabat Medical & Pharmacy School, Rabat Mohammed-V University, Rabat, Morocco., 2015

Novel hybrid multifunctional bacterial virus as delivery platform for targeting therapy to cancer., Fourth International Conference on Multifunctional Hybrid and Nanomaterials, Sitges, Barcelona, Spain., 2015

Bacteriophage/ AAV: an Engineered Bacteria Virus that Targets and Destroys Tumours in Preclinical Models., The Department of Medical Microbiology and Infectious Diseases. Cardiff University., Cardiff, 2015

Novel generation of bacteriophage-derived platform technologies for vaccine delivery, Vaccine Delivery Systems for the Future, Euroscicon, GlaxoSmithKline/Hertfordshire, 2013

Bacteriophage: From Bacteria to Efficient Targeted Systemic Gene Therapy Against Cancer, Qatar Foundation Annual Research Forum, Doha, Qatar., 2012

DUAL SYSTEMIC TUMOUR TARGETING WITH LIGAND-DIRECTED PHAGE AND GRP78 PROMOTER INDUCES REGRESSION OF GLIOBLASTOMA, British Neuro-oncology society international meeting, Manchester, United Kingdom., 2012

Invited Guest Lecture by Professor Geoffrey Pilkington, University of Portsmouth, Portsmouth, United Kingdom, 2012

A Hybrid Bacteriophage-Based Vector for Targeted Systemic Gene Delivery to Tumour Vasculature, Conference of the British Society of Gene Therapy, Royal Holloway University of London, 2010

Nanotechnology in the fields of Gene therapy, UK-Thailand Conference on Nanomedicine, Bangkok Thailand, 2010

Research Staff